Prothena Corporation PLC (PRTA) Stake Increased by Amalgamated Bank

Amalgamated Bank lifted its position in shares of Prothena Corporation PLC (NASDAQ:PRTA) by 11.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,731 shares of the biotechnology company’s stock after buying an additional 476 shares during the period. Amalgamated Bank’s holdings in Prothena Corporation PLC were worth $256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in PRTA. Bank of Montreal Can increased its holdings in shares of Prothena Corporation PLC by 6.7% during the 2nd quarter. Bank of Montreal Can now owns 1,858 shares of the biotechnology company’s stock worth $100,000 after buying an additional 117 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Prothena Corporation PLC by 187.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,375 shares of the biotechnology company’s stock worth $129,000 after buying an additional 1,549 shares during the last quarter. Ameritas Investment Partners Inc. acquired a new stake in shares of Prothena Corporation PLC during the 1st quarter worth approximately $167,000. Sei Investments Co. acquired a new stake in shares of Prothena Corporation PLC during the 2nd quarter worth approximately $176,000. Finally, SG Americas Securities LLC increased its holdings in shares of Prothena Corporation PLC by 16.2% during the 2nd quarter. SG Americas Securities LLC now owns 4,064 shares of the biotechnology company’s stock worth $220,000 after buying an additional 568 shares during the last quarter.

A number of brokerages have recently issued reports on PRTA. Royal Bank Of Canada restated a “buy” rating on shares of Prothena Corporation PLC in a report on Friday, September 29th. SunTrust Banks, Inc. restated a “buy” rating and set a $75.00 price target on shares of Prothena Corporation PLC in a report on Monday, October 2nd. ValuEngine downgraded shares of Prothena Corporation PLC from a “hold” rating to a “sell” rating in a report on Friday, October 6th. Jefferies Group LLC reiterated a “buy” rating and issued a $100.00 target price on shares of Prothena Corporation PLC in a report on Monday, October 2nd. Finally, BTIG Research dropped their target price on shares of Prothena Corporation PLC from $80.00 to $77.00 and set a “buy” rating for the company in a report on Friday, September 29th. One equities research analyst has rated the stock with a sell rating and fourteen have given a buy rating to the stock. Prothena Corporation PLC presently has a consensus rating of “Buy” and an average target price of $78.58.

Prothena Corporation PLC (NASDAQ:PRTA) last issued its quarterly earnings results on Tuesday, August 8th. The biotechnology company reported ($0.46) EPS for the quarter, topping the consensus estimate of ($0.89) by $0.43. Prothena Corporation PLC had a negative net margin of 527.56% and a negative return on equity of 33.20%. The firm had revenue of $26.81 million during the quarter, compared to analyst estimates of $16.08 million. During the same quarter in the prior year, the business posted ($1.18) earnings per share. Prothena Corporation PLC’s revenue for the quarter was up 7951.1% compared to the same quarter last year.

ILLEGAL ACTIVITY WARNING: “Prothena Corporation PLC (PRTA) Stake Increased by Amalgamated Bank” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/2956810/prothena-corporation-plc-prta-stake-increased-by-amalgamated-bank.html.

In related news, insider Karin L. Walker sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $64.89, for a total transaction of $324,450.00. Following the completion of the transaction, the insider now owns 5,000 shares of the company’s stock, valued at $324,450. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Tara Nickerson sold 17,500 shares of the company’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $63.60, for a total transaction of $1,113,000.00. Following the transaction, the insider now directly owns 19,500 shares of the company’s stock, valued at approximately $1,240,200. The disclosure for this sale can be found here. Insiders have sold 34,424 shares of company stock valued at $2,247,237 in the last ninety days. 3.10% of the stock is currently owned by company insiders.

About Prothena Corporation PLC

Prothena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company’s clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson’s disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Want to see what other hedge funds are holding PRTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prothena Corporation PLC (NASDAQ:PRTA).

Institutional Ownership by Quarter for Prothena Corporation PLC (NASDAQ:PRTA)

Receive News & Ratings for Prothena Corporation PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prothena Corporation PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.